Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose Lurasidone in Treatment Resistant Schizophrenia
NCT01569659Phase 4Completed
- Sponsor
- Northwestern University
- Start
- Oct 2011
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lurasidone in schizophrenia, sponsored by Northwestern University. Started Oct 2011; status: completed.
02
Drugs
lurasidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01569659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01569659.